Recap: Century Therapeutics Q3 Earnings


Century Therapeutics IPSC reported its Q3 earnings results on Thursday, November 9, 2023 at 07:00 AM.

Here's what investors need to know about the announcement.


Century Therapeutics missed estimated earnings by 7.84%, reporting an EPS of $-0.55 versus an estimate of $-0.51.

Revenue was down $2.08 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.02 which was followed by a 4.91% drop in the share price the next day.

Here's a look at Century Therapeutics's past performance:

Quarter Q2 2023 Q1 2023 Q4 2022 Q3 2022
EPS Estimate -0.54 -0.52 -0.59 -0.59
EPS Actual -0.56 -0.53 -0.55 -0.53
Revenue Estimate 1.14M 1.31M 1.97M 1.13M
Revenue Actual 99K 1.72M 521K 2.22M

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Century Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!